Page last updated: 2024-08-25

voriconazole and Critical Illness

voriconazole has been researched along with Critical Illness in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (28.57)	29.6817
2010's	22 (52.38)	24.3611
2020's	8 (19.05)	2.80

Authors

Authors	Studies
Argaud, L; Aubrun, F; Bienvenu, AL; Chidiac, C; Fellahi, JL; Gagnieu, MC; Goutelle, S; Leboucher, G; Leclerc, V; Menotti, J; Parant, F; Piriou, V; Plesa, A; Pradat, P; Richard, JC; Rimmelé, T; Tod, M	1
Feih, J; Juul, J; Vu, T	1
Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M	1
Liu, G; Qi, Y	1
Argaud, L; Aubrun, F; Bienvenu, AL; Chidiac, C; Fellahi, JL; Friggeri, A; Guerin, C; Guichon, C; Hernu, R; Leboucher, G; Menotti, J; Monard, C; Paulus, S; Piriou, V; Pradat, P; Rimmele, T	1
Chen, T; Gao, L; Li, H; Li, M; Li, Q; Qiang, W; Shi, Q; Wang, J; Wang, T; Wang, Y; Yan, J; Zhang, Y; Zheng, J; Zhou, L	1
Chittick, PJ; Peterson, EL; Richardson, CL	1
Chandrasekar, P; Pasula, S	1
Bassetti, M; Bouza, E	1
Blot, S; Bulpa, P; Dimopoulos, G; Forêt, F; Frantzeskaki, F; Kosmopoulos, M; Taccone, FS; Van den Abeele, AM; Vogelaers, D	1
Blot, S; Bulpa, P; Dimopoulos, G; Gomes, A; Meersseman, W; Mergulhão, P; Misset, B; Paiva, JA; Rello, J; Taccone, FS; Van den Abeele, AM; Vogelaers, D	1
Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S	1
Foerster, KI; Mahmoudi, M; Mikus, G; Seeßle, J; Vay, M	1
Castellanos-Ortega, Á; Gordon, M; Marqués, MR; Peruccioni, M; Poveda-Andrés, JL; Ramirez, P; Ruiz, J; Villarreal, E	1
Alastruey-Izquierdo, A; Calabuig, E; Frasquet, J; López-Hontangas, JL; Martínez, H; Mollar, J; Moret, AM; Pemán, J; Ramírez, P; Ruiz-Gaitán, A; Salavert-Lletí, M; Tasias, M; Zaragoza, Ó	1
Pea, F	1
Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D	1
Annaert, P; de Loor, H; Lagrou, K; Maertens, J; Spriet, I; Vanstraelen, K; Vercammen, I; Wauters, J	1
Aquilante, CL; Fish, DN; Kiser, TH; MacLaren, R; Rower, JE; Teitelbaum, I; Wempe, MF	1
Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP	1
Cai, S; Chen, W; Li, Y; Liang, F; Liu, X; Meng, D; Rui, J; Xiao, X; Xie, H; Yin, X; Zhang, T	1
Bakker, J; Egal, M; Hunfeld, NG; Koch, BC; van Gelder, T; van Schaik, RH; Weigel, JD	1
Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM	1
Chakrabarti, A; Chakravarty, C; Dutta, S; Gopalakrishnan, R; Jessani, LG; Jillwin, J; Roy, U; Rudramurthy, SM	1
Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L	1
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F	1
Baltopoulos, G; Despotelis, S; Evaggelopoulou, P; Evodia, E; Markantonis, SL; Myrianthefs, P; Panidis, D	1
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T	1
Böhme, A; Heinz, WJ; Silling, G	1
Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R	1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G	1
Annaert, P; Brüggemann, RJ; Lagrou, K; Meersseman, P; Spriet, I; Van Wijngaerden, E; Willems, L	1
Mohammedi, I; Padoin, C; Piens, MA; Robert, D	1
Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M	1
Pemán, J; Zaragoza, R	1
Burhenne, J; von Mach, MA; Weilemann, LS	1
Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H	1
Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J	1
Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG	1
Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H	1
Allepuz-Palau, A; Alvarez-Lerma, F; Angeles Leon, M; Garcia, MP; Iruretagoyena, JR; Luque-Gomez, P; Navarro, A; Sanchez-Ruiz, H	1
Joshi, R; Kohli, V; Sachdev, P; Taneja, V	1

Reviews

3 review(s) available for voriconazole and Critical Illness

Article	Year
Invasive mould infections in the ICU setting: complexities and solutions. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole	2017
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:10 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole	2013
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy. Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2006

Trials

6 trial(s) available for voriconazole and Critical Illness

Article	Year
Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:7 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; China; Computer Simulation; Critical Illness; Female; Humans; Lung Diseases; Male; Middle Aged; Models, Biological; Monte Carlo Method; Voriconazole; Young Adult	2015
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice. Current medical research and opinion, 2011, Volume: 27, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2011
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration. Therapeutic drug monitoring, 2011, Volume: 33, Issue:4 Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole	2011
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2012
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:5 Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2005
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole	2005

Other Studies

33 other study(ies) available for voriconazole and Critical Illness

Article	Year
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients. PloS one, 2021, Volume: 16, Issue:11 Topics: Antifungal Agents; Critical Illness; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; Voriconazole	2021
Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation. Journal of pharmacy practice, 2023, Volume: 36, Issue:4 Topics: Adult; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Intensive Care Units; Respiratory Distress Syndrome; Voriconazole; Young Adult	2023
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients. Clinical laboratory, 2022, Jun-01, Volume: 68, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole	2022
A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM. Journal of pharmaceutical and biomedical analysis, 2022, Oct-25, Volume: 220 Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Critical Illness; Drug Monitoring; Humans; Imipenem; Linezolid; Meropenem; Micafungin; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Tigecycline; Vancomycin; Voriconazole	2022
Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 93 Topics: Aged; Antifungal Agents; Candidemia; Caspofungin; Cohort Studies; Critical Illness; Female; Fluconazole; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Retrospective Studies; Treatment Outcome; Voriconazole	2020
Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy. Basic & clinical pharmacology & toxicology, 2020, Volume: 127, Issue:6 Topics: Administration, Intravenous; Age Factors; Aged; Antifungal Agents; China; Chromatography, High Pressure Liquid; Critical Illness; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Patient Safety; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin, Human; Sex Factors; Voriconazole	2020
Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:3 Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Male; Voriconazole	2021
Spontaneous Hemoptysis in a Patient With COVID-19. Chest, 2021, Volume: 160, Issue:1 Topics: Aged; Antifungal Agents; Aspergillus niger; Clinical Deterioration; COVID-19; Critical Illness; Critical Pathways; Diagnosis, Differential; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Pseudomonas aeruginosa; Radiography, Thoracic; Respiration, Artificial; SARS-CoV-2; Superinfection; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole	2021
Endomyocardial and pericardial aspergillosis in critically ill patients. Mycoses, 2017, Volume: 60, Issue:9 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Female; Heart Diseases; Humans; Immunocompetence; Immunocompromised Host; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Middle Aged; Myocardium; Pericardium; Risk Factors; Voriconazole	2017
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures. International journal of antimicrobial agents, 2017, Volume: 50, Issue:4 Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Clinical Decision-Making; Critical Illness; Delayed Diagnosis; Drug Therapy, Combination; Echinocandins; Female; Fungal Proteins; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Respiratory System; Treatment Outcome; Voriconazole	2017
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:7 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult	2018
No alteration of voriconazole concentration by plasmapheresis in a critically ill patient. European journal of clinical pharmacology, 2019, Volume: 75, Issue:2 Topics: Aged; Antifungal Agents; Critical Illness; Female; Granulomatosis with Polyangiitis; Humans; Invasive Pulmonary Aspergillosis; Plasmapheresis; Voriconazole	2019
Impact of voriconazole plasma concentrations on treatment response in critically ill patients. Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:4 Topics: Antifungal Agents; Bilirubin; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Plasma; Prospective Studies; Voriconazole	2019
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients. Expert review of anti-infective therapy, 2019, Volume: 17, Issue:4 Topics: Adult; Aged; Antifungal Agents; Candida; Candidemia; Case-Control Studies; Critical Illness; Disease Outbreaks; Drug Resistance, Viral; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Voriconazole	2019
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. International journal of antimicrobial agents, 2014, Volume: 43, Issue:2 Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole	2014
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Aged; Antifungal Agents; Bilirubin; Blood Proteins; Chromatography, Liquid; Critical Illness; Female; Humans; Hypoalbuminemia; Intensive Care Units; Invasive Pulmonary Aspergillosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Protein Binding; Serum Albumin; Tandem Mass Spectrometry; Voriconazole	2014
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Critical care (London, England), 2015, Feb-03, Volume: 19 Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Replacement Therapy; Therapeutics; Voriconazole	2015
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report. BMC infectious diseases, 2015, Apr-15, Volume: 15 Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating	2015
Gain-of-function single nucleotide variants of the CYP2C19 gene (CYP2C1917) can identify subtherapeutic voriconazole concentrations in critically ill patients: a case series. Intensive care medicine, 2015, Volume: 41, Issue:11* Topics: Antifungal Agents; Aspergillosis; Critical Illness; Cytochrome P-450 CYP2C19; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Voriconazole	2015
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole	2016
Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses, 2017, Volume: 60, Issue:6 Topics: Adult; Aged; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Critical Illness; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; India; Infant, Newborn; Male; Microbial Sensitivity Tests; Multigene Family; Probiotics; RNA, Ribosomal; Saccharomyces boulardii; Saccharomyces cerevisiae; Voriconazole	2017
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:4 Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole	2009
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis]. Der Anaesthesist, 2009, Volume: 58, Issue:3 Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole	2009
Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study. International journal of antimicrobial agents, 2010, Volume: 35, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Drug Monitoring; Female; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Middle Aged; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2010
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole	2010
Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange. Therapeutic drug monitoring, 2013, Volume: 35, Issue:1 Topics: Antifungal Agents; Antiphospholipid Syndrome; Critical Illness; Humans; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Pyrimidines; Triazoles; Voriconazole	2013
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy. BMC clinical pharmacology, 2006, Sep-18, Volume: 6 Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole	2006
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:6 Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole	2007
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5 Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole	2007
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:2 Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole	2008
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient. Therapeutic drug monitoring, 2008, Volume: 30, Issue:1 Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole	2008
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1 Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Critical Illness; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole	2008
Voriconazole in newborns. Indian pediatrics, 2008, Volume: 45, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole	2008